Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$10.52M
Expense Ratio	0.85%
PE Ratio	19.05
Shares Out	300,000
Dividend (ttm)	$0.23
Dividend Yield	0.62%
Ex-Dividend Date	Dec 31, 2024
Payout Frequency	n/a
Payout Ratio	12.13%

Volume	758
Open	36.67
Previous Close	36.70
Day's Range	36.67 - 36.79
52-Week Low	31.08
52-Week High	42.41
Beta	1.03
Holdings	28
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

65.50% of assets

Name	Symbol	Weight
Wayfair Inc.	W	7.30%
Penumbra, Inc.	PEN	7.30%
LivaNova PLC	LIVN	7.08%
Expand Energy Corporation	EXE	6.95%
Deutsche Bank Aktiengesellschaft	DBK	6.56%
Millicom International Cellular S.A.	TIGO	6.35%
Cardinal Health, Inc.	CAH	6.19%
CNX Resources Corporation	CNX	6.10%
The Bank of New York Mellon Corporation	BK	5.86%
ING Groep N.V.	ING	5.82%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of -9.23% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.96%.